PPAR-γ Modulation as a Novel Therapeutic Strategy for Scarring Alopecia

    Marta Bertolini, Jérémy Chéret, Jonathan A. Hardman, Fernando Acosta, Ralf Paus
    Image of study
    TLDR A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.
    The study from May 2018 investigated the effects of N-acetyl-GED (AGED), a PPAR-γ modulator, on scarring alopecia, particularly lichen planopilaris (LPP). It focused on whether AGED could protect human hair follicle epithelial stem cells (HFeSCs) from epithelial-mesenchymal-transition (EMT) or could reverse EMT in established LPP ex vivo. The study found that AGED successfully protected stem cells from EMT by maintaining E-cadherin levels and reducing the number of vimentin+ or SLUG+ cells. Additionally, AGED was able to partially rescue hair follicles from EMT and significantly reverse EMT in LPP-affected follicles, as shown by changes in E-cadherin, vimentin, SLUG expression, and K15+ cell numbers. These results indicate that PPAR-γ modulation with AGED is a promising approach for treating scarring alopecias like LPP that involve EMT of epithelial stem cells.
    Discuss this study in the Community →